Stable isotope-resolved metabolomics based on mass spectrometry: Methods and their applications DOI
Di Yu, Lina Zhou, Xinyu Liu

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2023, Volume and Issue: 160, P. 116985 - 116985

Published: Feb. 11, 2023

Language: Английский

Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking DOI Creative Commons
Zhiwei Zhou,

Mingdu Luo,

Haosong Zhang

et al.

Nature Communications, Journal Year: 2022, Volume and Issue: 13(1)

Published: Nov. 4, 2022

Abstract Liquid chromatography - mass spectrometry (LC-MS) based untargeted metabolomics allows to measure both known and unknown metabolites in the metabolome. However, metabolite annotation is a major challenge metabolomics. Here, we develop an approach, namely, knowledge-guided multi-layer network (KGMN), enable global from knowns unknowns The KGMN approach integrates three-layer networks, including knowledge-based metabolic reaction network, MS/MS similarity peak correlation network. To demonstrate principle, apply vitro enzymatic system different biological samples, with ~100–300 putative annotated each data set. Among them, >80% are corroborated silico tools. Finally, validate 5 that absent common libraries through repository mining synthesis of chemical standards. Together, enables efficient annotations, substantially advances discovery recurrent for samples model organisms, towards deciphering dark matter

Language: Английский

Citations

140

Advanced analytical and informatic strategies for metabolite annotation in untargeted metabolomics DOI Open Access
Yuping Cai, Zhiwei Zhou, Zheng‐Jiang Zhu

et al.

TrAC Trends in Analytical Chemistry, Journal Year: 2022, Volume and Issue: 158, P. 116903 - 116903

Published: Dec. 24, 2022

Language: Английский

Citations

54

Molecular networking as a natural products discovery strategy DOI Creative Commons
Mi Zhang, Kouharu Otsuki, Wei Li

et al.

Acta Materia Medica, Journal Year: 2023, Volume and Issue: 2(2)

Published: April 25, 2023

The rapid development of bioinformatics tools has recently broken through the bottleneck in natural products research. These advances have enabled researchers to rapidly separate and efficiently target discover previously undescribed molecules. Among these advances, tandem mass spectrometry molecular networking is a promising method for de-replicating complex mixtures, thus leading an accelerated revolution “art isolation” field. In this review we describe current networking-based metabolite analysis methods that are widely applied or implementable discovery research, metabolomics, related fields. main objective was summarize strategies can be implemented as alternative de-replication approaches efficient list examples successful applications combine with other techniques.

Language: Английский

Citations

33

Metabolomics in drug research and development: The recent advances in technologies and applications DOI Creative Commons
Huanhuan Pang, Zeping Hu

Acta Pharmaceutica Sinica B, Journal Year: 2023, Volume and Issue: 13(8), P. 3238 - 3251

Published: May 23, 2023

Emerging evidence has demonstrated the vital role of metabolism in various diseases or disorders. Metabolomics provides a comprehensive understanding biological systems. With advanced analytical techniques, metabolomics exhibits unprecedented significant value basic drug research, including disease mechanisms, identifying targets, and elucidating mode action drugs. More importantly, greatly accelerates development process by predicting pharmacokinetics, pharmacodynamics, response. In addition, facilitates exploration repurposing drug-drug interactions, as well personalized treatment strategies. Here, we briefly review recent advances technologies update our knowledge applications research development.

Language: Английский

Citations

33

Statistical methods and resources for biomarker discovery using metabolomics DOI Creative Commons
Najeha Anwardeen,

Ilhame Diboun,

Younes Mokrab

et al.

BMC Bioinformatics, Journal Year: 2023, Volume and Issue: 24(1)

Published: June 15, 2023

Abstract Metabolomics is a dynamic tool for elucidating biochemical changes in human health and disease. Metabolic profiles provide close insight into physiological states are highly volatile to genetic environmental perturbations. Variation metabolic can inform mechanisms of pathology, providing potential biomarkers diagnosis assessment the risk contracting With advancement high-throughput technologies, large-scale metabolomics data sources have become abundant. As such, careful statistical analysis intricate essential deriving relevant robust results that be deployed real-life clinical settings. Multiple tools been developed both interpretations. In this review, we survey approaches corresponding available discovery using metabolomics.

Language: Английский

Citations

29

Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches DOI Creative Commons
Agneesh Pratim Das, Subhash Mohan Agarwal

Molecular Diversity, Journal Year: 2023, Volume and Issue: 28(2), P. 901 - 925

Published: Jan. 21, 2023

Phytocompounds are a well-established source of drug discovery due to their unique chemical and functional diversities. In the area cancer therapeutics, several phytocompounds have been used till date design develop new drugs. One desired interests pharmaceutical companies researchers globally is that anti-cancer leads discovered, for which can be considered valuable source. Simultaneously, in recent years, growth computational approaches like virtual screening (VS), molecular dynamics (MD), pharmacophore modelling, Quantitative structure–activity relationship (QSAR), Absorption Distribution Metabolism Excretion Toxicity (ADMET), network biology, machine learning (ML) has gained importance efficiency, reduced time-consuming nature, cost-effectiveness. Therefore, present review amalgamates information on plant-based molecules identified lead from silico approaches. The mandate this discuss studies published last 5–6 years aim identify phytomolecules as against with help traditional well newer techniques pharmacology ML. This also lists databases webservers available public domain related harnessed discovery. It expected would useful pharmacologists, medicinal chemists, biologists, other involved development natural products (NPs) into clinically effective molecules. Reviewed niche phytomolecule-based respect current trends including learning.

Language: Английский

Citations

28

Novel Insights into the Adverse Health Effects of per- and Polyfluoroalkyl Substances on the Kidney via Human Urine Metabolomics DOI

Anen He,

Juan Li, Li Zhao

et al.

Environmental Science & Technology, Journal Year: 2023, Volume and Issue: 57(43), P. 16244 - 16254

Published: Oct. 18, 2023

Per- and polyfluoroalkyl substances (PFAS) receive significant research attention due to their potential adverse effects on human health. Evidence shows that the kidney is one of target organs PFAS. In occupational exposure scenarios, high PFAS concentrations may adversely affect metabolism, but whether this effect reflected in small metabolic molecules contained urine remains unknown. study, 72 matched serum samples from workers a fluorochemical manufactory as well 153 local residents were collected, 23 levels quantified. The Σ23PFAS 5.43 ± 1.02 μg/mL 201 46.9 ng/mL, respectively, while concentration was 6.18 0.76 ng/mL. For workers, urinary strongly correlated with (r = 0.57-0.93), indicating can be good indicator for levels. Further, nontargeted metabolomics study conducted. results association models, including Bayesian kernel machine regression, demonstrated positive correlations between key molecules. A total eight biomarkers associated identified, all them showed markers function. These findings provide first evidence serve matrix indicate health kidneys.

Language: Английский

Citations

27

Genome-scale metabolic network models for industrial microorganisms metabolic engineering: Current advances and future prospects DOI Creative Commons

Zhijin Gong,

Jiayao Chen, Xinyu Jiao

et al.

Biotechnology Advances, Journal Year: 2024, Volume and Issue: 72, P. 108319 - 108319

Published: Jan. 26, 2024

Language: Английский

Citations

14

Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease DOI Creative Commons

Jiali Lv,

Chang Pan, Yuping Cai

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: July 8, 2024

Abstract Risk prediction for subsequent cardiovascular events remains an unmet clinical issue in patients with coronary artery disease. We aimed to investigate prognostic metabolic biomarkers by considering both shared and distinct disturbance associated the composite individual events. Here, we conducted untargeted metabolomics analysis 333 incident matched controls. The were designated as death, myocardial infarction/stroke heart failure. A total of 23 differential metabolites majority middle long chain acylcarnitines. Distinct patterns revealed, glycerophospholipids alteration was specific Notably, addition markers significantly improved failure risk prediction. This study highlights potential significance plasma on tailed assessment events, strengthens understanding heterogenic mechanisms across different

Language: Английский

Citations

12

Metabolomic profiling reveals biomarkers for diverse flesh colors in jelly fungi (Auricularia cornea) DOI
Lei Ye, Bo Zhang,

Xuezhen Yang

et al.

Food Chemistry, Journal Year: 2024, Volume and Issue: 446, P. 138906 - 138906

Published: March 9, 2024

Language: Английский

Citations

11